The BRIC countries and exchange traded funds (ETFs) might be seeing even better days as the four countries meet this week to discuss economics and international cooperation.

The foreign ministers of the four BRIC countries – Brazil, Russia, India and China – are going to  cover topics such as food, energy, terrorism, climate change, finance, trade and nuclear proliferation over the three-day summit, reports Joanne Von Alroth for Investor’s Business Daily.

This is the first time the four countries are meeting exclusively, and many feel the quartet should be a part of the G-8 because of their strong economic growth. China and India are solid in manufacturing, while Russia and Brazil have got raw materials covered.

According the Goldman Sachs, the collective wealth of these countries will outshine that of the currently more prosperous G-6 countries (France, Germany, Italy, Japan, the U.K. and the U.S.) by 2050.

Investors have enjoyed the success of these countries, as the related ETFs have been showing solid performance.

Broad exposure to these economies is available in several funds if you can’t single out just country. SPDR S&P BRIC 40 (BIK) is up 26% since March and is barely a year old. Claymore/BNY BRIC (EEB) is up 31% on heavy trade over the same period. 

There are 49 BRIC-related ETFs to choose from, and here is a small sample:

  • iShares MSCI Brazil (EWZ): up 16.8% year-to-date
  • Market Vectors Russia (RSX): up 11.2% year-to-date
  • WisdomTree India Earnings (EPI): down 8.3% since inception
  • SPDR S&P China (GXC): down 10.3% year-to-date

The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Mr. Lydon serves as an independent trustee of certain mutual funds and ETFs that are managed by Guggenheim Investments; however, any opinions or forecasts expressed herein are solely those of Mr. Lydon and not those of Guggenheim Funds, Guggenheim Investments, Guggenheim Specialized Products, LLC or any of their affiliates. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.